tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LEXX Stock Latest News

Lexaria Bioscience Strengthens GLP-1 Drug Delivery Focus and Expands Patent Portfolio in 2024
Company AnnouncementsLexaria Bioscience Strengthens GLP-1 Drug Delivery Focus and Expands Patent Portfolio in 2024
21h ago
LEXX
Lexaria CEO says FY25 R&D will ‘remain concentrated’ on GLP-1 investigations
PremiumThe Fly
Lexaria CEO says FY25 R&D will ‘remain concentrated’ on GLP-1 investigations
23h ago
LEXX
Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright
PremiumThe Fly
Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright
7d ago
LEXX
Lexaria Bioscience files $50M mixed securities shelf
PremiumThe Fly
Lexaria Bioscience files $50M mixed securities shelf
9d ago
LEXX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
14d ago
ANIX
ERNA
Lexaria Bioscience Advances with Human Study for Oral Liraglutide
PremiumCompany AnnouncementsLexaria Bioscience Advances with Human Study for Oral Liraglutide
16d ago
LEXX
Lexaria’s human GLP-1 study 5 receives IRB approval
Premium
The Fly
Lexaria’s human GLP-1 study 5 receives IRB approval
16d ago
LEXX
Lexaria’s Oral Drug Shows Promising Results Against Eli Lilly’s Injection
Premium
Company Announcements
Lexaria’s Oral Drug Shows Promising Results Against Eli Lilly’s Injection
17d ago
LEXX
Lexaria Bioscience announces partial results from GLP-1-H24-3 study
PremiumThe Fly
Lexaria Bioscience announces partial results from GLP-1-H24-3 study
17d ago
LEXX
Lexaria Bioscience’s Phase 1b study starts patient dosing, says H.C. Wainwright
PremiumThe Fly
Lexaria Bioscience’s Phase 1b study starts patient dosing, says H.C. Wainwright
1M ago
LEXX
Lexaria Bioscience Initiates Promising Drug Study
PremiumCompany Announcements
Lexaria Bioscience Initiates Promising Drug Study
1M ago
LEXX
Lexaria Bioscience begins dosing for GLP-1 study #4
PremiumThe Fly
Lexaria Bioscience begins dosing for GLP-1 study #4
1M ago
LEXX
Lexaria Bioscience Bolsters Drug Delivery Strategy
PremiumCompany AnnouncementsLexaria Bioscience Bolsters Drug Delivery Strategy
1M ago
LEXX
Lexaria Bioscience forms Scientific Advisory Board
Premium
The Fly
Lexaria Bioscience forms Scientific Advisory Board
1M ago
LEXX
Lexaria Bioscience Welcomes New Chief Medical Advisor
Premium
Company Announcements
Lexaria Bioscience Welcomes New Chief Medical Advisor
1M ago
LEXX
Lexaria Bioscience appoints Michael Gibson as chief medical advisor
PremiumThe Fly
Lexaria Bioscience appoints Michael Gibson as chief medical advisor
1M ago
LEXX
Lexaria Bioscience Explores Oral Liraglutide Potential
PremiumCompany Announcements
Lexaria Bioscience Explores Oral Liraglutide Potential
2M ago
LEXX
Lexaria Bioscience engages CRO for human pilot study of DehydraTEHC-liraglutide
PremiumThe Fly
Lexaria Bioscience engages CRO for human pilot study of DehydraTEHC-liraglutide
2M ago
LEXX
Lexaria Bioscience files to sell 4.55M shares of common stock for holders
PremiumThe Fly
Lexaria Bioscience files to sell 4.55M shares of common stock for holders
2M ago
LEXX
Lexaria Bioscience’s Promising Outlook on GLP-1 Drugs
PremiumCompany AnnouncementsLexaria Bioscience’s Promising Outlook on GLP-1 Drugs
2M ago
LEXX
Lexaria Bioscience’s Oral Tirzepatide Study Progresses
Premium
Company Announcements
Lexaria Bioscience’s Oral Tirzepatide Study Progresses
2M ago
LEXX
Lexaria Bioscience completes dosing for GLP-1 human pilot study #3
Premium
The Fly
Lexaria Bioscience completes dosing for GLP-1 human pilot study #3
2M ago
LEXX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >